Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 11/2003

01-11-2003 | Erratum

Trends in hypertension management in Type I diabetes across Europe, 1989/1990 – 1997/1999

Authors: S. S. Soedamah-Muthu, H. M. Colhoun, H. Abrahamian, N. N. Chan, R. Mangili, G. P. Reboldi, J. H. Fuller,   the EURODIAB Prospective Complications Study Group

Published in: Diabetologia | Issue 11/2003

Login to get access

Excerpt

In the footnote of Table 2, the last item in this table “Controlled” should be indicated with the letter “f”, meaning “Proportion of treated hypertensives”. …
Metadata
Title
Trends in hypertension management in Type I diabetes across Europe, 1989/1990 – 1997/1999
Authors
S. S. Soedamah-Muthu
H. M. Colhoun
H. Abrahamian
N. N. Chan
R. Mangili
G. P. Reboldi
J. H. Fuller
  the EURODIAB Prospective Complications Study Group
Publication date
01-11-2003
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 11/2003
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-003-1210-9

Other articles of this Issue 11/2003

Diabetologia 11/2003 Go to the issue

Comment

Comment

Article

Associations between hyperglycaemia and somatic transversion mutations in mitochondrial DNA of people with diabetes mellitus

Article

Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects

Article

13C NMR analysis reveals a link between L-glutamine metabolism, D-glucose metabolism and γ-glutamyl cycle activity in a clonal pancreatic beta-cell line

Author’s Reply

Author’s reply

Article

Processed meat intake and incidence of Type 2 diabetes in younger and middle-aged women
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits